NESLA – North of England Life Sciences Accelerator

The North of England Life Sciences Accelerator (NESLA) is looking for early stage businesses or those with a business idea in the life sciences and healthcare sector.

NESLA is offering an opportunity to apply for an integrated programme of support through collaboration with the BioHub at Alderley Park, Manchester Science Partnerships, The N8 Research Partnership, the Northern Health Science Alliance, Alderley Park Ventures and Catapult Ventures.
 
Successful applicants will be invited to join NELSA and benefit from:

  • A place on the BioCity Accelerator programme
  • Seed funding via Catapult Ventures & Alderley Park Ventures
  • 1:1 coaching
  • Mentorship via the UK wide Expert Network
  • Access to clinicians / clinical validation via the NHSA
  • Advice & introductions to investors to secure further funding
  • Free virtual tenancy at BioHub at Alderley Park
  • Access to shared facilities & analytical laboratory at Alderley Park

To find out more about NESLA and to apply, visit: www.biocity.co.uk/accelerator/north-of-england-life-science-accelerator

Featured News

Inovus wins March Merseyside Innovation Award with Turnkey Commercialisation Service

A  service developed by Inovus has won the March Merseyside Innovation Award. The Turnkey Commercialisation Service provides universities and clinicians...

Read more

New Call for Proposals – CMFT/MIMIT

Use of Wearable and Sensor Technology and the Internet of Things for Healthcare This Call is a part of...

Read more

Job Vacancy: Director of IP and Business Partnerships (MHV)

Director of IP and Business Partnerships (Manchester Health Ventures Ltd) Main area: Manager Grade: 8d Contract: Permanent Hours: 37.5...

Read more

TRUSTECH continues support for Merseyside Innovation Awards

For the third successive year, TRUSTECH is proud to be the exclusive healthcare sponsor of the Merseyside Innovation Awards...

Read more

Subscribe for Updates

Register to receive newsletters and information about new programmes and events.